|
Volumn 21, Issue 5, 2000, Pages 321-327
|
VAP: Strategies for prevention and treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
ANTIBIOTIC AGENT;
AZITHROMYCIN;
BETA LACTAM ANTIBIOTIC;
CEPHALOSPORIN DERIVATIVE;
CHLORHEXIDINE GLUCONATE;
COTRIMOXAZOLE;
DALFOPRISTIN PLUS QUINUPRISTIN;
HISTAMINE H2 RECEPTOR ANTAGONIST;
PSEUDOMONIC ACID;
QUINOLONE DERIVATIVE;
RANITIDINE;
RECOMBINANT ERYTHROPOIETIN;
SUCRALFATE;
VANCOMYCIN;
ADULT RESPIRATORY DISTRESS SYNDROME;
ANEMIA;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
BACTERIAL INFECTION;
CLINICAL TRIAL;
DECUBITUS;
DISINFECTION;
HOSPITAL INFECTION;
HUMAN;
INFECTION CONTROL;
LUNG LAVAGE;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
PNEUMONIA;
PSEUDOMONAS AERUGINOSA;
REVIEW;
RISK FACTOR;
STRESS ULCER;
VENTILATOR;
|
EID: 0034115658
PISSN: 0194259X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (11)
|
References (10)
|